The Glazner lab (University of Manitoba, Winnipeg) is seeking applications for a post-doc research associate to follow up on our recent publication “Secreted amyloid precursor protein alpha activates neuronal insulin receptors and prevents diabetes-induced encephalopathy” (Experimental Neurology; 303, 29–37, January 2018). The focus of the Glazner lab is to explore mechanistic connection between diabetes and Alzheimer’s disease. The post-doc associate will be free to design and explore their own research ideas, within the context of diabetes and Alzheimer’s disease. The post-doc associate will have opportunities to perform both in vitro and in vivo experiments. Available animal models include the SAMP8 mouse model of Alzheimer’s and the STZ diabetic model.
We are looking to fill this position immediately. Interested applicants should email their CV and contact information for 2 references (please email materials to email@example.com).
PhD (or have successfully defended thesis) in neuroscience, biochemistry, physiology, pharmacology, or related discipline at the time of starting in the lab.
PhD obtained in the last 0-3 years.
Ability to work independently and generate own research ideas.
Internal Number: 8585
About Gordon Glazner lab at the University of Manitoba
The Glazner in Winnipeg, MB is focused on studying the mechanisms that underlie neurodegeneration in Alzheimer's disease